All lobbying filings

HARMONY BIOSCIENCES

Lobbying for HARMONY BIOSCIENCES · pharmaceuticals

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Pennsylvania · House · Senate · $180,000.00 expenses · posted Jul 20, 2026

Official filing document

Bills named in this filing 4

S 3019
No Big Blockbuster Bailouts Act
HR 1414
Cameron’s Law
HR 1492
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic can…
HR 1672
Maintaining Investments in New Innovation Act

Lobbying activity 1

Pharmacy

S. 3019 - No Big Blockbuster Bailouts Act (NOBBBA) Cameron's Law (HR 1414) EPIC Act (HR 1492, S 832) HR 1672 Maintaining Investments in New Innovation Act Issues related to protecting patient access to medicines Issues related to protecting orphan drug policies Issues related to most-favored-nation policies

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.